Registered entities
IMMUNOMIC THERAPEUTICS, INC.
Reg. No. 203878827United States
Innovation
15 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 2,568 times.
| Year | Filings |
|---|---|
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 8 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 5 |
| 2024 | 6 |
| 2025 | 7 |
Social engagement
Social engagement: 3.7K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
9 investors on record; lead investors include HLB.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 22% |
| Angel & family office | 2 | 22% |
| Other / undisclosed | 5 | 56% |
Recent activity
18 Jun 2026
Leadership hire
Senior Director of Clinical Operations
16 Jun 2026
Milestone
regulatory